Cholinergic Nicotinic Agonist [EPC]

Cholinergic Nicotinic Agonist [EPC] was reported 61214 times

These side effects are most commonly reported by patients taking drugs of the Cholinergic Nicotinic Agonist [EPC] class:

# Drug class Count
0 DRUG INEFFECTIVE 7659
1 NICOTINE DEPENDENCE 6185
2 NAUSEA 4699
3 INTENTIONAL DRUG MISUSE 3782
4 APPLICATION SITE ERYTHEMA 3567
5 APPLICATION SITE PRURITUS 3517
6 DIZZINESS 2627
7 PRODUCT QUALITY ISSUE 2503
8 MALAISE 2409
9 PRODUCT ADHESION ISSUE 2362
10 HEADACHE 2194
11 WRONG TECHNIQUE IN PRODUCT USAGE PROCESS 1813
12 VOMITING 1777
13 OVERDOSE 1697
14 TREATMENT NONCOMPLIANCE 1599
15 DRUG ADMINISTRATION ERROR 1529
16 DYSPNOEA 1491
17 INSOMNIA 1400
18 APPLICATION SITE RASH 1378
19 ANXIETY 1356
20 HYPERSENSITIVITY 1309
21 APPLICATION SITE PAIN 1279
22 RASH 1241
23 APPLICATION SITE IRRITATION 1229
24 ABNORMAL DREAMS 1192
25 PRURITUS 1079
26 PAIN 1074
27 FEELING ABNORMAL 1070
28 FATIGUE 1046
29 DIARRHOEA 1013
30 DRUG DEPENDENCE 988
31 APPLICATION SITE REACTION 984
32 DYSPEPSIA 952
33 OFF LABEL USE 891
34 MACULAR DEGENERATION 830
35 PAIN IN EXTREMITY 817
36 COUGH 797
37 PALPITATIONS 793
38 FOETAL EXPOSURE DURING PREGNANCY 791
39 ORAL DISCOMFORT 787
40 PRODUCT USE ISSUE 787
41 ASTHENIA 779
42 THROAT IRRITATION 775
43 INCORRECT DRUG ADMINISTRATION DURATION 756
44 ERYTHEMA 755
45 NIGHTMARE 754
46 APPLICATION SITE SWELLING 747
47 CHEST PAIN 742
48 TREMOR 741
49 HEART RATE INCREASED 739
50 EXPIRED PRODUCT ADMINISTERED 726
51 DEPRESSION 702
52 ABDOMINAL DISCOMFORT 693
53 PRODUCT COMPLAINT 688
54 DYSGEUSIA 662
55 ABDOMINAL PAIN UPPER 654
56 HICCUPS 649
57 TOXICITY TO VARIOUS AGENTS 643
58 CONSTIPATION 634
59 INCORRECT DOSE ADMINISTERED 630
60 HYPERHIDROSIS 603
61 NERVOUSNESS 599
62 WEIGHT DECREASED 589
63 PYREXIA 574
64 URTICARIA 541
65 WEIGHT INCREASED 540
66 ABDOMINAL PAIN 520
67 CONDITION AGGRAVATED 511
68 APPLICATION SITE URTICARIA 493
69 DRUG DOSE OMISSION 493
70 DRUG INTERACTION 491
71 DEPENDENCE 487
72 PNEUMONIA 485
73 IRRITABILITY 481
74 THERAPEUTIC PRODUCT EFFECT INCOMPLETE 477
75 HYPERTENSION 475
76 BLOOD PRESSURE INCREASED 472
77 MATERNAL EXPOSURE DURING PREGNANCY 472
78 UNDERDOSE 468
79 OROPHARYNGEAL PAIN 467
80 SOMNOLENCE 462
81 FALL 446
82 DRUG ABUSE 445
83 LOSS OF CONSCIOUSNESS 429
84 DEATH 428
85 PARAESTHESIA 424
86 ARTHRALGIA 410
87 ACUTE KIDNEY INJURY 404
88 PARAESTHESIA ORAL 404
89 DRUG WITHDRAWAL SYNDROME NEONATAL 402
90 CHRONIC OBSTRUCTIVE PULMONARY DISEASE 390
91 CHEST DISCOMFORT 388
92 STOMATITIS 387
93 BLOOD GLUCOSE INCREASED 385
94 CONFUSIONAL STATE 384
95 MYOCARDIAL INFARCTION 384
96 ANAEMIA 381
97 APPLICATION SITE VESICLES 379
98 BACK PAIN 377
99 DRUG WITHDRAWAL SYNDROME 369
100 PRODUCT USE IN UNAPPROVED INDICATION 366
101 DRUG ABUSER 365
102 HYPOAESTHESIA 365
103 PHARMACEUTICAL PRODUCT COMPLAINT 365
104 PREMATURE BABY 365
105 DECREASED APPETITE 358
106 DRUG HYPERSENSITIVITY 351
107 CHRONIC KIDNEY DISEASE 343
108 INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION 339
109 DRY MOUTH 338
110 INTENTIONAL PRODUCT MISUSE 336
111 HYPOTENSION 330
112 BURNING SENSATION 325
113 ORAL PAIN 324
114 SUICIDAL IDEATION 324
115 MYALGIA 307
116 SLEEP DISORDER 306
117 FEELING JITTERY 297
118 AGITATION 295
119 GASTROOESOPHAGEAL REFLUX DISEASE 290
120 INTENTIONAL PRODUCT USE ISSUE 289
121 RENAL FAILURE 288
122 INCORRECT PRODUCT ADMINISTRATION DURATION 284
123 PRODUCT DOSE OMISSION 279
124 FLATULENCE 276
125 ABDOMINAL DISTENSION 274
126 WITHDRAWAL SYNDROME 274
127 INAPPROPRIATE SCHEDULE OF DRUG ADMINISTRATION 271
128 RECTAL HAEMORRHAGE 269
129 CHRONIC SINUSITIS 262
130 INFUSION RELATED REACTION 261
131 DENTAL CARIES 260
132 WHEEZING 260
133 PREMATURE DELIVERY 258
134 CEREBROVASCULAR ACCIDENT 257
135 MUSCLE SPASMS 256
136 ASTHMA 255
137 GLOSSODYNIA 255
138 STRESS 252
139 APPLICATION SITE DERMATITIS 251
140 EMOTIONAL DISTRESS 249
141 PRODUCT DOSE OMISSION ISSUE 249
142 HAEMATOCHEZIA 248
143 HALLUCINATION 248
144 COLITIS 247
145 PAIN IN JAW 241
146 TACHYCARDIA 239
147 FREQUENT BOWEL MOVEMENTS 238
148 ACCIDENTAL EXPOSURE TO PRODUCT 236
149 GAIT DISTURBANCE 236
150 PROCEDURAL PAIN 235
151 TOOTHACHE 234
152 APPLICATION SITE BURN 233
153 OEDEMA PERIPHERAL 233
154 MIGRAINE 228
155 SKIN IRRITATION 228
156 COLITIS ULCERATIVE 223
157 DERMATITIS CONTACT 222
158 ILLNESS 221
159 ORAL CANDIDIASIS 221
160 RETCHING 221
161 RESTLESSNESS 219
162 FEELING HOT 216
163 VISION BLURRED 216
164 SEIZURE 215
165 DEHYDRATION 214
166 EXPOSURE DURING PREGNANCY 214
167 SYNCOPE 213
168 PRODUCTIVE COUGH 212
169 PERIPHERAL SWELLING 206
170 ADVERSE EVENT 203
171 GINGIVAL PAIN 203
172 ANGER 201
173 VAGINAL DISCHARGE 200
174 THERAPEUTIC RESPONSE UNEXPECTED 199
175 APPLICATION SITE PAPULES 196
176 EUPHORIC MOOD 195
177 DISTURBANCE IN ATTENTION 194
178 PROCTITIS 193
179 FEMALE GENITAL TRACT FISTULA 192
180 RADICULOPATHY 192
181 DEPRESSED MOOD 190
182 NEUTROPENIA 189
183 BLISTER 188
184 THROAT TIGHTNESS 188
185 VAGINAL FLATULENCE 188
186 LOW BIRTH WEIGHT BABY 186
187 CONVULSION 183
188 RESPIRATORY FAILURE 182
189 SWELLING FACE 179
190 MEDICATION ERROR 178
191 URINARY TRACT INFECTION 177
192 APPLICATION SITE WARMTH 176
193 ADVERSE DRUG REACTION 175
194 COMPLETED SUICIDE 175
195 DRUG INTOLERANCE 174
196 PANIC ATTACK 174
197 SUBSTANCE ABUSE 174
198 SWELLING 171
199 HOSPITALISATION 169
200 DYSPHAGIA 168
201 PRURITUS GENERALISED 168
202 BRONCHITIS 167
203 MEMORY IMPAIRMENT 166
204 PULMONARY OEDEMA 166
205 ILL-DEFINED DISORDER 165
206 CARDIAC ARREST 164
207 NASOPHARYNGITIS 164
208 PULMONARY EMBOLISM 163
209 ALOPECIA 161
210 ACCIDENTAL OVERDOSE 159
211 TOOTH DISORDER 159
212 DIABETES MELLITUS 158
213 STOMACH DISCOMFORT 158
214 THERMAL BURN 157
215 WRONG TECHNIQUE IN DRUG USAGE PROCESS 157
216 EXPIRED DRUG ADMINISTERED 156
217 MOUTH ULCERATION 156
218 AGGRESSION 155
219 SEPSIS 155
220 SINUSITIS 155
221 TOOTH DISCOLOURATION 155
222 ANHEDONIA 154
223 NO ADVERSE EVENT 154
224 MUSCULAR WEAKNESS 153
225 INJURY 151
226 CHILLS 149
227 NECK PAIN 149
228 PSYCHOMOTOR HYPERACTIVITY 148
229 DYSPHONIA 147
230 PHARYNGEAL OEDEMA 147
231 DISCOMFORT 146
232 APPLICATION SITE DISCOLOURATION 145
233 SWOLLEN TONGUE 145
234 DISORIENTATION 144
235 HOT FLUSH 141
236 DYSPNOEA EXERTIONAL 139
237 CRYING 137
238 INFLUENZA 137
239 PRODUCT TASTE ABNORMAL 136
240 LETHARGY 135
241 BLOOD PRESSURE DECREASED 134
242 RASH PRURITIC 134
243 ERUCTATION 132
244 INTENTIONAL OVERDOSE 132
245 MENTAL DISORDER 131
246 EXPOSURE VIA BREAST MILK 130
247 TOOTH FRACTURE 130
248 POOR QUALITY SLEEP 129
249 DRUG EXPOSURE DURING PREGNANCY 127
250 APPLICATION SITE PARAESTHESIA 125
251 BALANCE DISORDER 125
252 HYPOXIA 125
253 LUNG NEOPLASM MALIGNANT 125
254 EMPHYSEMA 123
255 GASTROINTESTINAL HAEMORRHAGE 123
256 MOOD SWINGS 123
257 SALIVARY HYPERSECRETION 123
258 OXYGEN SATURATION DECREASED 121
259 AMNESIA 120
260 EXPOSURE DURING BREAST FEEDING 120
261 CONTUSION 119
262 DRUG EFFECT LESS THAN EXPECTED 119
263 DYSARTHRIA 117
264 EPISTAXIS 117
265 GENERAL PHYSICAL HEALTH DETERIORATION 117
266 HAEMOGLOBIN DECREASED 117
267 RASH GENERALISED 117
268 SPEECH DISORDER 117
269 ABNORMAL BEHAVIOUR 116
270 CARDIAC DISORDER 116
271 THROMBOCYTOPENIA 116
272 ECONOMIC PROBLEM 115
273 HEART RATE IRREGULAR 115
274 TOBACCO USER 115
275 TOOTH LOSS 114
276 INCORRECT ROUTE OF PRODUCT ADMINISTRATION 113
277 OROPHARYNGEAL DISCOMFORT 113
278 COLD SWEAT 112
279 RASH ERYTHEMATOUS 112
280 VISUAL IMPAIRMENT 112
281 CELLULITIS 111
282 JOINT SWELLING 111
283 NASAL CONGESTION 111
284 SKIN BURNING SENSATION 111
285 GASTRIC DISORDER 110
286 INFECTION 109
287 ATRIAL FIBRILLATION 108
288 HYPOKALAEMIA 108
289 SUICIDE ATTEMPT 108
290 DRUG TOXICITY 107
291 TONGUE DISCOLOURATION 107
292 TOOTH EROSION 107
293 PHARYNGOLARYNGEAL PAIN 106
294 VERTIGO 106
295 NONSPECIFIC REACTION 105
296 PSYCHOTIC DISORDER 105
297 PLEURAL EFFUSION 104
298 RASH MACULAR 103
299 INCREASED APPETITE 102
300 MOOD ALTERED 102
301 RHINORRHOEA 102
302 BLOOD CHOLESTEROL INCREASED 101
303 BLOOD CREATININE INCREASED 101
304 HYPOAESTHESIA ORAL 101
305 MENTAL STATUS CHANGES 101
306 SKIN DISCOLOURATION 101
307 ANGINA PECTORIS 100
308 DELIRIUM 100
309 SNEEZING 100
310 END STAGE RENAL DISEASE 99
311 OSTEOPOROSIS 99
312 APPLICATION SITE EXFOLIATION 98
313 JAUNDICE NEONATAL 98
314 COMA 97
315 FULL BLOOD COUNT ABNORMAL 97
316 DEEP VEIN THROMBOSIS 96
317 LIP SWELLING 96
318 THROMBOSIS 96
319 INFLUENZA LIKE ILLNESS 95
320 TENSION 95
321 ANAPHYLACTIC REACTION 94
322 FEBRILE NEUTROPENIA 94
323 UNRESPONSIVE TO STIMULI 94
324 CARDIAC FAILURE CONGESTIVE 93
325 DRY SKIN 93
326 VENTRICULAR SEPTAL DEFECT 93
327 HYPONATRAEMIA 92
328 INCORRECT ROUTE OF DRUG ADMINISTRATION 92
329 MUSCULOSKELETAL PAIN 92
330 FEAR 91
331 MUSCULOSKELETAL STIFFNESS 91
332 NEUROPATHY PERIPHERAL 91
333 SKIN DISORDER 90
334 TONGUE DISCOMFORT 90
335 GASTROINTESTINAL DISORDER 88
336 LUNG DISORDER 88
337 CARDIAC FAILURE 87
338 EATING DISORDER 87
339 HAEMORRHAGE 87
340 CAESAREAN SECTION 86
341 ROAD TRAFFIC ACCIDENT 86
342 CHOKING 84
343 EMOTIONAL DISORDER 84
344 PALLOR 84
345 AGEUSIA 83
346 DRUG EFFECTIVE FOR UNAPPROVED INDICATION 83
347 ORAL MUCOSAL BLISTERING 83
348 DRUG SCREEN POSITIVE 82
349 FLUSHING 82
350 MULTIPLE DRUG OVERDOSE 82
351 SENSATION OF FOREIGN BODY 82
352 APPLICATION SITE DRYNESS 81
353 INJECTION SITE PAIN 81
354 DEPRESSED LEVEL OF CONSCIOUSNESS 80
355 MENTAL IMPAIRMENT 79
356 MUSCULOSKELETAL CHEST PAIN 79
357 RESPIRATORY DISTRESS 79
358 CARDIO-RESPIRATORY ARREST 78
359 POOR FEEDING INFANT 78
360 ACCIDENTAL EXPOSURE 77
361 GINGIVAL BLEEDING 77
362 HAEMOPTYSIS 77
363 HYPERSOMNIA 77
364 MIDDLE INSOMNIA 77
365 OBSTRUCTIVE AIRWAYS DISORDER 77
366 TRUNCUS ARTERIOSUS PERSISTENT 77
367 DRUG INEFFECTIVE FOR UNAPPROVED INDICATION 76
368 FEELING COLD 76
369 SEPTIC SHOCK 75
370 TOBACCO ABUSE 75
371 ABORTION SPONTANEOUS 74
372 ELECTROCARDIOGRAM QT PROLONGED 74
373 EYE SWELLING 74
374 GLOSSITIS 74
375 OEDEMA 74
376 OEDEMA MOUTH 74
377 HALLUCINATION, AUDITORY 73
378 SENSORY DISTURBANCE 73
379 HYPERKALAEMIA 72
380 LOSS OF PERSONAL INDEPENDENCE IN DAILY ACTIVITIES 72
381 RENAL IMPAIRMENT 72
382 RESPIRATORY ARREST 72
383 SEDATION 72
384 BRADYCARDIA 71
385 CORONARY ARTERY DISEASE 71
386 HYPERGLYCAEMIA 71
387 RENAL FAILURE ACUTE 71
388 RENAL INJURY 71
389 TINNITUS 71
390 ABORTION INDUCED 70
391 BONE PAIN 70
392 C-REACTIVE PROTEIN INCREASED 70
393 DRUG EFFECT DECREASED 70
394 SKIN EXFOLIATION 70
395 TOBACCO POISONING 70
396 UNEVALUABLE EVENT 70
397 WHITE BLOOD CELL COUNT INCREASED 70
398 COVID-19 69
399 NEOPLASM MALIGNANT 69
400 APPLICATION SITE SCAR 68
401 ARTHRITIS 68
402 BIPOLAR DISORDER 68
403 EXTRA DOSE ADMINISTERED 68
404 HYPOGLYCAEMIA 68
405 PANCREATITIS 68
406 RHESUS INCOMPATIBILITY 68
407 SINUS TACHYCARDIA 68
408 ACUTE MYOCARDIAL INFARCTION 67
409 ATELECTASIS 67
410 CONTRAINDICATED PRODUCT ADMINISTERED 67
411 PARANOIA 67
412 PRODUCT SUBSTITUTION ISSUE 67
413 PULMONARY MASS 67
414 SKIN REACTION 67
415 THERAPY CESSATION 67
416 BONE DENSITY DECREASED 66
417 LACRIMATION INCREASED 66
418 MATERNAL DRUGS AFFECTING FOETUS 66
419 PRODUCT PHYSICAL ISSUE 66
420 THINKING ABNORMAL 66
421 TONGUE DISORDER 66
422 DRUG EFFECT INCOMPLETE 65
423 GINGIVAL DISORDER 65
424 PRODUCT SELECTION ERROR 65
425 SLEEP APNOEA SYNDROME 65
426 ANGIOEDEMA 64
427 NASAL DISCOMFORT 64
428 ORAL MUCOSAL DISCOLOURATION 64
429 SLEEP DISORDER DUE TO A GENERAL MEDICAL CONDITION 64
430 APPLICATION SITE INFLAMMATION 63
431 OSTEOARTHRITIS 63
432 RESPIRATORY DISORDER 63
433 SKIN ULCER 63
434 TYPE 2 DIABETES MELLITUS 63
435 WHITE BLOOD CELL COUNT DECREASED 63
436 ACUTE RESPIRATORY FAILURE 62
437 DISEASE PROGRESSION 62
438 DYSURIA 62
439 HAEMATEMESIS 62
440 OSTEOPENIA 62
441 PLATELET COUNT DECREASED 62
442 POOR QUALITY PRODUCT ADMINISTERED 62
443 UPPER RESPIRATORY TRACT INFECTION 62
444 APPLICATION SITE BRUISE 61
445 APPLICATION SITE HYPERSENSITIVITY 61
446 DRY THROAT 61
447 HEART RATE DECREASED 61
448 NIGHT SWEATS 61
449 PNEUMONIA ASPIRATION 61
450 ANOREXIA 60
451 APPLICATION SITE DISCOMFORT 60
452 APPLICATION SITE SCAB 60
453 ARRHYTHMIA 60
454 CONGENITAL CARDIOVASCULAR ANOMALY 60
455 HALLUCINATION, VISUAL 60
456 HEAD INJURY 60
457 OCULAR HYPERAEMIA 60
458 ORAL DISORDER 60
459 PSORIASIS 60
460 SURGERY 60
461 FLUID RETENTION 59
462 HEART DISEASE CONGENITAL 59
463 NEPHROGENIC ANAEMIA 59
464 POLLAKIURIA 59
465 PRODUCT ADMINISTRATION INTERRUPTED 59
466 THIRST 59
467 ALCOHOL ABUSE 58
468 DYSKINESIA 58
469 INITIAL INSOMNIA 58
470 MOBILITY DECREASED 58
471 SKIN LESION 58
472 CARDIAC SEPTAL DEFECT 57
473 CHOKING SENSATION 57
474 DYSSTASIA 57
475 GINGIVAL SWELLING 57
476 LYMPHADENOPATHY 57
477 PANIC REACTION 57
478 HEPATIC STEATOSIS 56
479 LOCAL SWELLING 56
480 LOWER RESPIRATORY TRACT INFECTION 56
481 MUSCLE TWITCHING 56
482 RHABDOMYOLYSIS 56
483 RIB FRACTURE 56
484 TRANSIENT ISCHAEMIC ATTACK 56
485 DRUG USE DISORDER 55
486 HEPATIC ENZYME INCREASED 55
487 DRUG EFFECT INCREASED 54
488 FOETAL DISTRESS SYNDROME 54
489 HYPERLIPIDAEMIA 54
490 LIMB DISCOMFORT 54
491 SEROTONIN SYNDROME 54
492 BLOOD CREATINE PHOSPHOKINASE INCREASED 53
493 CIRCUMSTANCE OR INFORMATION CAPABLE OF LEADING TO MEDICATION ERROR 53
494 ERECTILE DYSFUNCTION 53
495 ORTHOSTATIC HYPOTENSION 53
496 SPUTUM DISCOLOURED 53
497 UPPER-AIRWAY COUGH SYNDROME 53
498 VAGINAL HAEMORRHAGE 53
499 ISCHAEMIC STROKE 52
500 PULMONARY CONGESTION 52
501 SCAR 52
502 HYPOTHYROIDISM 51
503 PRODUCT ADMINISTERED AT INAPPROPRIATE SITE 51
504 TRANSFUSION 51
505 INTESTINAL OBSTRUCTION 50
506 MALIGNANT NEOPLASM PROGRESSION 50
507 PRODUCT STORAGE ERROR 50
508 RASH PAPULAR 50
509 SCHIZOPHRENIA 50
510 THERAPEUTIC PRODUCT EFFECT DECREASED 50
511 UPPER GASTROINTESTINAL HAEMORRHAGE 50
512 ALANINE AMINOTRANSFERASE INCREASED 49
513 BREECH PRESENTATION 49
514 DRUG LEVEL INCREASED 49
515 OBESITY 49
516 OROPHARYNGEAL BLISTERING 49
517 THERAPEUTIC RESPONSE DECREASED 49
518 TOOTH INJURY 49
519 BRAIN OEDEMA 48
520 CHOLELITHIASIS 48
521 COGNITIVE DISORDER 48
522 FIBROMYALGIA 48
523 MALNUTRITION 48
524 MANIA 48
525 OBSESSIVE THOUGHTS 48
526 RHINITIS 48
527 BLOOD POTASSIUM DECREASED 47
528 CARDIOVASCULAR DISORDER 47
529 GINGIVITIS 47
530 LEUKOPENIA 47
531 MAJOR DEPRESSION 47
532 METABOLIC ACIDOSIS 47
533 MOVEMENT DISORDER 47
534 MULTIPLE SCLEROSIS RELAPSE 47
535 MUSCLE TIGHTNESS 47
536 NEPHROLITHIASIS 47
537 PRODUCT PACKAGING ISSUE 47
538 ACNE 46
539 CHEST X-RAY ABNORMAL 46
540 ENCEPHALOPATHY 46
541 EPILEPSY 46
542 INFLAMMATION 46
543 TONGUE BLISTERING 46
544 TOOTH ABSCESS 46
545 BLOOD SODIUM DECREASED 45
546 BLOOD TRIGLYCERIDES INCREASED 45
547 CARDIOMEGALY 45
548 EAR PAIN 45
549 FAECES DISCOLOURED 45
550 HYPOACUSIS 45
551 INTERVERTEBRAL DISC PROTRUSION 45
552 PANCREATITIS ACUTE 45
553 THERAPY INTERRUPTED 45
554 THROAT CLEARING 45
555 HUNGER 44
556 MYOCLONUS 44
557 NASAL OBSTRUCTION 44
558 OESOPHAGEAL PAIN 44
559 RIB DEFORMITY 44
560 SCAB 44
561 SKIN LACERATION 44
562 STAPHYLOCOCCAL INFECTION 44
563 ACCIDENTAL EXPOSURE TO PRODUCT BY CHILD 43
564 ARTERIOSCLEROSIS 43
565 CROHN^S DISEASE 43
566 HAEMATOCRIT DECREASED 43
567 LIVER FUNCTION TEST ABNORMAL 43
568 PRODUCT USE COMPLAINT 43
569 REVERSIBLE AIRWAYS OBSTRUCTION 43
570 APATHY 42
571 APPLICATION SITE EROSION 42
572 DRUG PRESCRIBING ERROR 42
573 FORMICATION 42
574 GASTRITIS 42
575 LEUKOCYTOSIS 42
576 LIMB INJURY 42
577 PREMATURE LABOUR 42
578 BLOOD GLUCOSE DECREASED 41
579 CEREBRAL HAEMORRHAGE 41
580 DRY EYE 41
581 ENERGY INCREASED 41
582 IMPAIRED WORK ABILITY 41
583 MUSCULOSKELETAL DISCOMFORT 41
584 POISONING 41
585 POST-TRAUMATIC STRESS DISORDER 41
586 PRESYNCOPE 41
587 RENAL DISORDER 41
588 RESTLESS LEGS SYNDROME 41
589 SCRATCH 41
590 TONGUE ULCERATION 41
591 TUBULOINTERSTITIAL NEPHRITIS 41
592 URINARY INCONTINENCE 41
593 URINARY RETENTION 41
594 BLOOD POTASSIUM INCREASED 40
595 EYE PAIN 40
596 GASTRIC ULCER 40
597 MYOCARDITIS 40
598 PRODUCT AVAILABILITY ISSUE 40
599 RASH MACULO-PAPULAR 40
600 ARTERIOSCLEROSIS CORONARY ARTERY 39
601 BLOOD PRESSURE SYSTOLIC INCREASED 39
602 DIVERTICULITIS 39
603 HIP FRACTURE 39
604 MITRAL VALVE INCOMPETENCE 39
605 PERICARDIAL EFFUSION 39
606 PNEUMONITIS 39
607 PRESCRIBED OVERDOSE 39
608 WOUND 39
609 CIRCULATORY COLLAPSE 38
610 CYANOSIS 38
611 FOOT FRACTURE 38
612 HAEMATURIA 38
613 INTENTIONAL UNDERDOSE 38
614 NEUTROPHIL COUNT INCREASED 38
615 OBSESSIVE-COMPULSIVE DISORDER 38
616 PANCYTOPENIA 38
617 PRODUCT ADMINISTRATION ERROR 38
618 SINUS CONGESTION 38
619 SMALL FOR DATES BABY 38
620 AGITATION NEONATAL 37
621 BLOOD PRESSURE FLUCTUATION 37
622 CEREBRAL INFARCTION 37
623 FEELING DRUNK 37
624 RHEUMATOID ARTHRITIS 37
625 SINUS DISORDER 37
626 CHROMATURIA 36
627 DIPLOPIA 36
628 ECZEMA 36
629 HERPES ZOSTER 36
630 HOMICIDAL IDEATION 36
631 MIOSIS 36
632 PRE-ECLAMPSIA 36
633 SPINAL OSTEOARTHRITIS 36
634 APHASIA 35
635 APHTHOUS STOMATITIS 35
636 APPLICATION SITE BRUISING 35
637 ARTHROPATHY 35
638 ASPARTATE AMINOTRANSFERASE INCREASED 35
639 DEAFNESS 35
640 INTERNATIONAL NORMALISED RATIO INCREASED 35
641 JAUNDICE 35
642 MULTIPLE SCLEROSIS 35
643 OLIGOHYDRAMNIOS 35
644 PNEUMOTHORAX 35
645 PRODUCT PHYSICAL CONSISTENCY ISSUE 35
646 CARDIAC FLUTTER 34
647 CATARACT 34
648 CORONARY ARTERY OCCLUSION 34
649 CYSTITIS 34
650 EOSINOPHIL COUNT INCREASED 34
651 FACE OEDEMA 34
652 HEPATITIS C 34
653 INTENTIONAL SELF-INJURY 34
654 JOINT INJURY 34
655 NERVE INJURY 34
656 NERVOUS SYSTEM DISORDER 34
657 OSTEOMYELITIS 34
658 PREGNANCY 34
659 TROPONIN INCREASED 34
660 ANKLE FRACTURE 33
661 APPLICATION SITE HAEMORRHAGE 33
662 APPLICATION SITE PERSPIRATION 33
663 CARDIOMYOPATHY 33
664 EYE DISORDER 33
665 HAEMORRHOIDS 33
666 HEMIPARESIS 33
667 HIATUS HERNIA 33
668 INTENTIONAL MISUSE 33
669 PHOTOSENSITIVITY REACTION 33
670 PRODUCT PACKAGE ASSOCIATED INJURY 33
671 RED BLOOD CELL COUNT DECREASED 33
672 SENSITIVITY OF TEETH 33
673 SHOCK 33
674 TREMOR NEONATAL 33
675 VENTRICULAR TACHYCARDIA 33
676 VIRAL INFECTION 33
677 ABDOMINAL PAIN LOWER 32
678 BODY TEMPERATURE INCREASED 32
679 ELECTROCARDIOGRAM ABNORMAL 32
680 FOETAL DISORDER 32
681 IMPAIRED HEALING 32
682 LEFT VENTRICULAR HYPERTROPHY 32
683 LIP DISCOLOURATION 32
684 LYMPHOCYTE COUNT DECREASED 32
685 MULTIPLE DRUG OVERDOSE ACCIDENTAL 32
686 MYDRIASIS 32
687 PAROSMIA 32
688 POOR QUALITY DRUG ADMINISTERED 32
689 RENAL TUBULAR NECROSIS 32
690 TOOTH INFECTION 32
691 VITAMIN B12 DEFICIENCY 32
692 AFFECTIVE DISORDER 31
693 ALCOHOL INTERACTION 31
694 APHTHOUS ULCER 31
695 BLINDNESS 31
696 BLOOD ALKALINE PHOSPHATASE INCREASED 31
697 BONE LOSS 31
698 DISABILITY 31
699 FOETAL GROWTH RESTRICTION 31
700 FUNGAL INFECTION 31
701 HEPATIC FAILURE 31
702 LACTIC ACIDOSIS 31
703 REVERSIBLE CEREBRAL VASOCONSTRICTION SYNDROME 31
704 ULCER 31
705 ACUTE RESPIRATORY DISTRESS SYNDROME 30
706 BARRETT^S OESOPHAGUS 30
707 DERMATITIS 30
708 DEVICE ISSUE 30
709 EYE IRRITATION 30
710 EYE PRURITUS 30
711 FACIAL PAIN 30
712 HYPERPARATHYROIDISM SECONDARY 30
713 INTERVERTEBRAL DISC DEGENERATION 30
714 MOUTH SWELLING 30
715 ORAL MUCOSAL EXFOLIATION 30
716 PLATELET COUNT INCREASED 30
717 PRODUCT PREPARATION ERROR 30
718 REBOUND ACID HYPERSECRETION 30
719 UPPER LIMB FRACTURE 30
720 URINE ODOUR ABNORMAL 30
721 ACTIVITIES OF DAILY LIVING IMPAIRED 29
722 APPLICATION SITE DISCHARGE 29
723 BLOOD BILIRUBIN INCREASED 29
724 DIABETIC KETOACIDOSIS 29
725 EAR INFECTION 29
726 HEAD DISCOMFORT 29
727 LIBIDO DECREASED 29
728 LIVER INJURY 29
729 MUCOSAL INFLAMMATION 29
730 PULMONARY HYPERTENSION 29
731 REGURGITATION 29
732 SKIN ODOUR ABNORMAL 29
733 THERAPY NON-RESPONDER 29
734 THROAT CANCER 29
735 TOBACCO WITHDRAWAL SYMPTOMS 29
736 WRONG TECHNIQUE IN DEVICE USAGE PROCESS 29
737 ACCIDENTAL DEATH 28
738 ANTIPSYCHOTIC DRUG LEVEL INCREASED 28
739 APHONIA 28
740 APPLICATION SITE HYPERAESTHESIA 28
741 ASPIRATION 28
742 BLOOD COUNT ABNORMAL 28
743 DEVICE FAILURE 28
744 EAR DISCOMFORT 28
745 EJECTION FRACTION DECREASED 28
746 GINGIVAL DISCOMFORT 28
747 HYPERVENTILATION 28
748 IRRITABLE BOWEL SYNDROME 28
749 LOWER LIMB FRACTURE 28
750 NEUTROPHIL COUNT DECREASED 28
751 ORAL MUCOSAL ERUPTION 28
752 PRE-EXISTING CONDITION IMPROVED 28
753 RESPIRATORY TRACT INFECTION 28
754 TACHYPNOEA 28
755 TRANSAMINASES INCREASED 28
756 UMBILICAL HERNIA 28
757 ADVERSE REACTION 27
758 ANOSMIA 27
759 ATAXIA 27
760 BONE DISORDER 27
761 BREATH ODOUR 27
762 DIZZINESS POSTURAL 27
763 DROOLING 27
764 DRUG REACTION WITH EOSINOPHILIA AND SYSTEMIC SYMPTOMS 27
765 ELECTROLYTE IMBALANCE 27
766 GAMBLING DISORDER 27
767 GINGIVAL ULCERATION 27
768 GLYCOSYLATED HAEMOGLOBIN INCREASED 27
769 JAW FRACTURE 27
770 JOINT STIFFNESS 27
771 LABORATORY TEST ABNORMAL 27
772 LACERATION 27
773 LOSS OF LIBIDO 27
774 MYOCARDIAL ISCHAEMIA 27
775 PRODUCT PACKAGING QUANTITY ISSUE 27
776 RENAL CYST 27
777 RESPIRATORY DEPRESSION 27
778 SKIN PLAQUE 27
779 SKIN WARM 27
780 VISUAL DISTURBANCE 27
781 ABASIA 26
782 COAGULOPATHY 26
783 DELUSION 26
784 DERMATITIS ALLERGIC 26
785 GASTROINTESTINAL PAIN 26
786 GRAND MAL CONVULSION 26
787 LEFT VENTRICULAR DYSFUNCTION 26
788 PERIODONTITIS 26
789 PERSONALITY CHANGE 26
790 PHARYNGEAL SWELLING 26
791 PRODUCT COLOUR ISSUE 26
792 QUALITY OF LIFE DECREASED 26
793 SCHIZOAFFECTIVE DISORDER 26
794 SUICIDAL BEHAVIOUR 26
795 TRICUSPID VALVE INCOMPETENCE 26
796 VASCULITIS 26
797 BACTERAEMIA 25
798 BREAST CANCER 25
799 CARDIAC MURMUR 25
800 CHEILITIS 25
801 DISSEMINATED INTRAVASCULAR COAGULATION 25
802 FEEDING DISORDER 25
803 GINGIVAL RECESSION 25
804 INCONTINENCE 25
805 KIDNEY INFECTION 25
806 LIP DISORDER 25
807 MYOCARDIAL STUNNING 25
808 NASAL POLYPS 25
809 OSTEONECROSIS 25
810 PHARYNGEAL DISORDER 25
811 PHARYNGEAL HYPOAESTHESIA 25
812 PRODUCT SOLUBILITY ABNORMAL 25
813 RED CELL DISTRIBUTION WIDTH INCREASED 25
814 SPUTUM PURULENT 25
815 SUBSTANCE DEPENDENCE 25
816 TASTE DISORDER 25
817 TENDERNESS 25
818 TREATMENT FAILURE 25
819 VISUAL ACUITY REDUCED 25
820 AKATHISIA 24
821 ALCOHOL USE 24
822 ARTERIAL OCCLUSIVE DISEASE 24
823 BACK DISORDER 24
824 BRONCHOSPASM 24
825 CARPAL TUNNEL SYNDROME 24
826 CLEFT PALATE 24
827 CONCOMITANT DISEASE AGGRAVATED 24
828 DIABETES MELLITUS INADEQUATE CONTROL 24
829 HYPERCHLORHYDRIA 24
830 MASS 24
831 MOUTH INJURY 24
832 MULTIPLE FRACTURES 24
833 NASAL OEDEMA 24
834 PERIPHERAL COLDNESS 24
835 PHARYNGITIS 24
836 PNEUMONIA STREPTOCOCCAL 24
837 ROTATOR CUFF SYNDROME 24
838 SEASONAL ALLERGY 24
839 SECONDARY IMMUNODEFICIENCY 24
840 SEXUAL DYSFUNCTION 24
841 ABNORMAL FAECES 23
842 ALCOHOL POISONING 23
843 BLOOD MAGNESIUM DECREASED 23
844 BLOOD PRESSURE ABNORMAL 23
845 BLOOD URINE PRESENT 23
846 BRAIN INJURY 23
847 BRONCHIOLITIS 23
848 BURSITIS 23
849 CLOSTRIDIUM DIFFICILE COLITIS 23
850 DIAPHRAGMATIC DISORDER 23
851 DRUG TOLERANCE 23
852 HAEMATOMA 23
853 HYPERCHOLESTEROLAEMIA 23
854 HYPOPHAGIA 23
855 IMPAIRED DRIVING ABILITY 23
856 INTENTIONAL DOSE OMISSION 23
857 LIVER DISORDER 23
858 METABOLIC ENCEPHALOPATHY 23
859 METHAEMOGLOBINAEMIA 23
860 MICROCEPHALY 23
861 OPHTHALMOPLEGIA 23
862 OSTEONECROSIS OF JAW 23
863 PARALYSIS 23
864 PRODUCT ODOUR ABNORMAL 23
865 PULMONARY GRANULOMA 23
866 RENAL PAIN 23
867 RESPIRATORY TRACT CONGESTION 23
868 SMALL INTESTINAL OBSTRUCTION 23
869 SNORING 23
870 SOMNAMBULISM 23
871 TOOTH EXTRACTION 23
872 ADRENAL INSUFFICIENCY 22
873 ALCOHOLISM 22
874 AORTIC ARTERIOSCLEROSIS 22
875 APPLICATION SITE ULCER 22
876 BETA HAEMOLYTIC STREPTOCOCCAL INFECTION 22
877 CHOLESTASIS 22
878 CLOSTRIDIUM TEST POSITIVE 22
879 CYTOKINE RELEASE SYNDROME 22
880 DEMENTIA 22
881 DISEASE RECURRENCE 22
882 DRUG DETOXIFICATION 22
883 EXERCISE TOLERANCE DECREASED 22
884 EXTRAPYRAMIDAL DISORDER 22
885 GENERALISED TONIC-CLONIC SEIZURE 22
886 INJECTION SITE REACTION 22
887 JAW DISORDER 22
888 LIP PAIN 22
889 MOUTH HAEMORRHAGE 22
890 MULTIPLE INJURIES 22
891 NEONATAL RESPIRATORY DISTRESS SYNDROME 22
892 PATENT DUCTUS ARTERIOSUS 22
893 PHOTOPHOBIA 22
894 POTENTIATING DRUG INTERACTION 22
895 PRESCRIPTION DRUG USED WITHOUT A PRESCRIPTION 22
896 PRIAPISM 22
897 PRODUCT LABEL ISSUE 22
898 SELF-INJURIOUS IDEATION 22
899 SUPRAVENTRICULAR TACHYCARDIA 22
900 AFFECT LABILITY 21
901 BEDRIDDEN 21
902 BLOOD UREA INCREASED 21
903 DECUBITUS ULCER 21
904 DYSTONIA 21
905 ELECTROCARDIOGRAM QRS COMPLEX PROLONGED 21
906 EOSINOPHILIA 21
907 FLANK PAIN 21
908 FRUSTRATION TOLERANCE DECREASED 21
909 GINGIVAL BLISTER 21
910 HERNIA 21
911 HYPERAESTHESIA 21
912 HYPOKINESIA 21
913 HYPOVOLAEMIA 21
914 INCREASED UPPER AIRWAY SECRETION 21
915 NOCTURIA 21
916 ORAL MUCOSAL ERYTHEMA 21
917 PARTIAL SEIZURES 21
918 POST PROCEDURAL COMPLICATION 21
919 PREMATURE SEPARATION OF PLACENTA 21
920 PRODUCT DISPENSING ERROR 21
921 PULMONARY FIBROSIS 21
922 SALIVA DISCOLOURATION 21
923 SPINAL FRACTURE 21
924 TARDIVE DYSKINESIA 21
925 VENTRICULAR EXTRASYSTOLES 21
926 ACCIDENT 20
927 ANAL INCONTINENCE 20
928 ASCITES 20
929 BLOOD CALCIUM INCREASED 20
930 BLOOD IMMUNOGLOBULIN E INCREASED 20
931 BRONCHIAL HYPERREACTIVITY 20
932 BRONCHIAL SECRETION RETENTION 20
933 BRONCHIAL WALL THICKENING 20
934 CARDIOGENIC SHOCK 20
935 COMPULSIVE SHOPPING 20
936 DECREASED ACTIVITY 20
937 DIVERTICULUM 20
938 DYSLIPIDAEMIA 20
939 FEELING OF BODY TEMPERATURE CHANGE 20
940 FEMUR FRACTURE 20
941 FOAMING AT MOUTH 20
942 GASTROENTERITIS 20
943 GASTROENTERITIS VIRAL 20
944 GINGIVAL DISCOLOURATION 20
945 HEPATOCELLULAR INJURY 20
946 HYPOTHERMIA 20
947 INJECTION SITE ERYTHEMA 20
948 LOOSE TOOTH 20
949 MASTICATION DISORDER 20
950 MEDIASTINAL MASS 20
951 MULTI-ORGAN FAILURE 20
952 MYCOBACTERIAL INFECTION 20
953 NECROSIS ISCHAEMIC 20
954 PRODUCT AFTER TASTE 20
955 PRODUCT DOSE OMISSION IN ERROR 20
956 PULMONARY EOSINOPHILIA 20
957 SENSORY LOSS 20
958 SKIN SWELLING 20
959 SOCIAL AVOIDANT BEHAVIOUR 20
960 SUBDURAL HAEMATOMA 20
961 TONSILLECTOMY 20
962 UROSEPSIS 20
963 VASODILATATION 20
964 VITAMIN D DEFICIENCY 20
965 ACUTE CORONARY SYNDROME 19
966 ADENOIDECTOMY 19
967 ANAPHYLACTIC SHOCK 19
968 BLINDNESS TRANSIENT 19
969 CLOSTRIDIUM DIFFICILE INFECTION 19
970 COUNTERFEIT PRODUCT ADMINISTERED 19
971 DRUG DIVERSION 19
972 FEELING OF RELAXATION 19
973 GAIT INABILITY 19
974 GENERALISED OEDEMA 19
975 GLAUCOMA 19
976 HEPATOMEGALY 19
977 HYPERCALCAEMIA 19
978 HYPERPHAGIA 19
979 HYPOTONIA 19
980 IDIOPATHIC INTERSTITIAL PNEUMONIA 19
981 IMPAIRED GASTRIC EMPTYING 19
982 INAPPROPRIATE ANTIDIURETIC HORMONE SECRETION 19
983 INJECTION SITE PRURITUS 19
984 INJECTION SITE SWELLING 19
985 JOINT DISLOCATION 19
986 LUNG DIFFUSION DISORDER 19
987 MATERNAL EXPOSURE DURING BREAST FEEDING 19
988 MUSCLE ATROPHY 19
989 MUSCLE RIGIDITY 19
990 MUSCLE STRAIN 19
991 ORAL PRURITUS 19
992 PELVIC PAIN 19
993 POSTMORTEM BLOOD DRUG LEVEL INCREASED 19
994 SKIN ABRASION 19
995 THERAPEUTIC PRODUCT EFFECT VARIABLE 19
996 THYROID DISORDER 19
997 ACUTE HEPATIC FAILURE 18
998 ALCOHOL WITHDRAWAL SYNDROME 18
999 APPLICATION SITE BLEEDING 18